Instantaneous Amplitude and Frequency Modulations Detect the Footprint of Rotational Activity and Reveal Stable Driver Regions as Targets for Persistent Atrial Fibrillation Ablation.


Journal

Circulation research
ISSN: 1524-4571
Titre abrégé: Circ Res
Pays: United States
ID NLM: 0047103

Informations de publication

Date de publication:
30 08 2019
Historique:
pubmed: 2 8 2019
medline: 9 7 2020
entrez: 2 8 2019
Statut: ppublish

Résumé

Costly proprietary panoramic multielectrode (64-256) acquisition systems are being increasingly used together with conventional electroanatomical mapping systems for persistent atrial fibrillation (PersAF) ablation. However, such approaches target alleged drivers (rotational/focal) regardless of their activation frequency dynamics. To test the hypothesis that stable regions of higher than surrounding instantaneous frequency modulation (iFM) drive PersAF and determine whether rotational activity is specific for such regions. First, novel single-signal algorithms based on instantaneous amplitude modulation (iAM) and iFM to detect rotational-footprints without panoramic multielectrode acquisition systems were tested in 125 optical movies from 5 ex vivo Langendorff-perfused PersAF sheep hearts (sensitivity/specificity, 92.6/97.5%; accuracy, 2.5-mm) and in computer simulations. Then, 16 pigs underwent high-rate atrial pacing to develop PersAF. After a median (interquartile range [IQR]) of 4.4 (IQR, 2.5-9.9) months of high-rate atrial pacing followed by 4.1 (IQR, 2.7-5.4) months of self-sustained PersAF, pigs underwent in vivo high-density electroanatomical atrial mapping (4920 [IQR, 4435-5855] 8-second unipolar signals per map). The first 4 out of 16 pigs were used to adapt ex vivo optical proccessing of iFM/iAM to in vivo electrical signals. In the remaining 12 out of 16 pigs, regions of higher than surrounding average iFM were considered leading-drivers. Two leading-driver + rotational-footprint maps were generated 2.6 (IQR, 2.4-2.9) hours apart to test leading-driver spatiotemporal stability and guide ablation. Leading-driver regions (2.5 [IQR, 2.0-4.0] regions/map) exactly colocalized (95.7%) in the 2 maps, and their ablation terminated PersAF in 92.3% of procedures (radiofrequency until termination, 16.9 [IQR, 9.2-35.8] minutes; until nonsustainability, 20.4 [IQR, 12.8-44.0] minutes). Rotational-footprints were found at every leading-driver region, albeit most (76.8% [IQR, 70.5%-83.6%]) were located outside. Finally, the translational ability of this approach was tested in 3 PersAF redo patients. Both rotational-footprints and spatiotemporally stable leading-driver regions can be located using iFM/iAM algorithms without panoramic multielectrode acquisition systems. In pigs, ablation of leading-driver regions usually terminates PersAF and prevents its sustainability. Rotational activations are sensitive but not specific to such regions. Single-signal iFM/iAM algorithms could be integrated into conventional electroanatomical mapping systems to improve driver detection accuracy and reduce the cost of patient-tailored/mechanistic approaches.

Identifiants

pubmed: 31366278
doi: 10.1161/CIRCRESAHA.119.314930
pmc: PMC6735936
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

609-627

Références

Cardiovasc Res. 2013 Aug 1;99(3):576-85
pubmed: 23612586
Circ Arrhythm Electrophysiol. 2017 Dec;10(12):null
pubmed: 29254947
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):650-8
pubmed: 22722660
J Am Coll Cardiol. 2014 Dec 16;64(23):2455-67
pubmed: 25500229
Heart Rhythm. 2006 Nov;3(11):1295-305
pubmed: 17074635
Eur Heart J. 2014 Jan;35(2):86-97
pubmed: 23935092
Circ Arrhythm Electrophysiol. 2012 Dec;5(6):1160-7
pubmed: 23051840
Nature. 1998 Mar 5;392(6671):75-8
pubmed: 9510249
Eur Heart J. 2015 Sep 14;36(35):2390-401
pubmed: 26059724
N Engl J Med. 2015 May 7;372(19):1812-22
pubmed: 25946280
Circ Arrhythm Electrophysiol. 2015 Apr;8(2):447-55
pubmed: 25740825
Circulation. 2016 Aug 9;134(6):486-98
pubmed: 27462069
J Am Coll Cardiol. 2012 Aug 14;60(7):628-36
pubmed: 22818076
Heart Rhythm. 2016 Sep;13(9):1868-77
pubmed: 27241354
Circ Arrhythm Electrophysiol. 2017 May;10(5):e004899
pubmed: 28500175
Heart Rhythm. 2018 Oct;15(10):1577-1582
pubmed: 29803023
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):313-20
pubmed: 21540439
Circ Arrhythm Electrophysiol. 2016 Jan;9(1):e002481
pubmed: 26729850
Heart Rhythm. 2017 Jul;14(7):1087-1096
pubmed: 28259694
Circ Res. 2017 Apr 28;120(9):1396-1398
pubmed: 28450363
IEEE Trans Biomed Eng. 2017 Feb;64(2):310-318
pubmed: 27101596
Circulation. 2014 Aug 12;130(7):530-8
pubmed: 25028391
Heart Rhythm. 2016 Jun;13(6):1215-20
pubmed: 26829116
J Am Coll Cardiol. 2017 Jan 24;69(3):303-321
pubmed: 28104073
J Cardiovasc Electrophysiol. 2016 Jun;27(6):661-9
pubmed: 26918971
Ann Biomed Eng. 2001 Jan;29(1):47-59
pubmed: 11219507
J Cardiovasc Electrophysiol. 2014 Apr;25(4):371-379
pubmed: 24806529
Circ Arrhythm Electrophysiol. 2018 May;11(5):e006119
pubmed: 29743170
Circ Res. 2000 Mar 3;86(4):408-17
pubmed: 10700445
Circulation. 2014 Apr 8;129(14):1472-82
pubmed: 24463369
Circulation. 2018 Mar 6;137(10):1027-1038
pubmed: 29129827
Science. 1995 Nov 17;270(5239):1222-3; author reply 1224-5
pubmed: 7502055

Auteurs

Jorge G Quintanilla (JG)

From the Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (J.G.Q., J.M.A.-A., J.J., D.F.-R.).
Arrhythmia Unit, Cardiology Department, Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain (J.G.Q., N.P.-C., J.P.-V., D.F.-R.).
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain (J.G.Q., N.P.-C., J.J., J.P.-V., D.F.-R.).

José Manuel Alfonso-Almazán (JM)

From the Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (J.G.Q., J.M.A.-A., J.J., D.F.-R.).

Nicasio Pérez-Castellano (N)

Arrhythmia Unit, Cardiology Department, Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain (J.G.Q., N.P.-C., J.P.-V., D.F.-R.).
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain (J.G.Q., N.P.-C., J.J., J.P.-V., D.F.-R.).

Sandeep V Pandit (SV)

Center for Arrhythmia Research, Department of Internal Medicine, University of Michigan, Ann Arbor (S.V.P., J.J.).

José Jalife (J)

From the Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (J.G.Q., J.M.A.-A., J.J., D.F.-R.).
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain (J.G.Q., N.P.-C., J.J., J.P.-V., D.F.-R.).
Center for Arrhythmia Research, Department of Internal Medicine, University of Michigan, Ann Arbor (S.V.P., J.J.).

Julián Pérez-Villacastín (J)

From the Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (J.G.Q., J.M.A.-A., J.J., D.F.-R.).
Arrhythmia Unit, Cardiology Department, Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain (J.G.Q., N.P.-C., J.P.-V., D.F.-R.).
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain (J.G.Q., N.P.-C., J.J., J.P.-V., D.F.-R.).

David Filgueiras-Rama (D)

From the Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (J.G.Q., J.M.A.-A., J.J., D.F.-R.).
Arrhythmia Unit, Cardiology Department, Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain (J.G.Q., N.P.-C., J.P.-V., D.F.-R.).
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain (J.G.Q., N.P.-C., J.J., J.P.-V., D.F.-R.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH